GELS
Gelteq Ltd (GELS)
Healthcare • NASDAQ • $0.47+0.86%
Key Fundamentals
- Symbol
- GELS
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $0.47
- Daily Change
- +0.86%
- Market Cap
- $5.03M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $3.51
- 52W Low
- $0.44
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
About Gelteq Ltd
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Company websiteResearch GELS on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.